Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Team IDs 2 pathways through which chromosomes are rearranged

09.09.2013
Discovery provides target to potentially halt the process, prevent cancers

Biologists reported today in Nature that they have identified two pathways through which chromosomes are rearranged in mammalian cells. These types of changes are associated with some cancers and inherited disorders in people.

"Our finding provides a target to prevent these rearrangements, so we could conceivably prevent cancer in some high-risk people," said senior author Edward P. (Paul) Hasty, D.V.M., of the School of Medicine at The University of Texas Health Science Center at San Antonio. Partial funding came from the Cancer Therapy & Research Center at the UT Health Science Center San Antonio.

The two pathways rearrange chromosomes by recombining DNA repeats that are naturally found in the genome, Dr. Hasty said. DNA, the chemical substance of genes, denatures and replicates during cell division and other processes. Repeats are sequences of DNA that are duplicated.

Both pathways are important for the synthesis of DNA. "Therefore, we propose that chromosomal rearrangements occur as DNA is being synthesized," Dr. Hasty said.

The experiments were conducted with mouse embryonic stem cells grown in tissue culture. The team measured the incidence of DNA repeats recombining in normal cells. This is called "repeat fusion." The scientists then looked for incidence of repeat fusion in cells affected by several genetic mutations. This analysis identified the two pathways and showed large, complicated rearrangements that involved DNA repeats on multiple chromosomes.

During cell division, DNA is coiled into pairs of threadlike structures called the chromosomes. Each human cell has 22 numbered pairs of chromosomes called autosomes. The sex chromosomes are the 23rd pair in cells and determine a person's gender. Females have two X chromosomes, while males have an X and a Y chromosome.

"We hope the new findings will help us better understand the mechanisms that cause chromosomal instability, which causes some cancers in people," Dr. Hasty said.

At the Health Science Center, Dr. Hasty is a professor in the Department of Molecular Medicine, has a laboratory at the UT Institute of Biotechnology, and is a faculty member of the Barshop Institute for Longevity and Aging Studies.

This work was supported by the National Institutes of Health (1 RO1 CA123203-01A1 to Drs. Paul Hasty and Cristina Montagna, 2P01AG017242-12 to Dr. Hasty, P30CA013330 to Dr. Montagna) and with support from the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (P30 CA054174).

Two Replication Fork Maintenance Pathways Fuse Inverted Repeats to Rearrange Chromosomes

DOI: 10.1038/nature12500

Lingchuan Hu1, Tae Moon Kim1, Mi Young Son1, Sung-A Kim1, Cory L. Holland1, Satoshi Tateishi2, Dong Hyun Kim1, P. Renee Yew1, Cristina Montagna3, Lavinia C. Dumitrache1,4, and Paul Hasty1

1Department of Molecular Medicine/Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, Texas 78245-3207, USA

2Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Honjo 2-2-1 Kumamoto 860-0811 Japan

3Department of Genetics, Albert Einstein College of Medicine of Yeshiva University, Bronx, N.Y. 10461

4Current address: Department of Genetics & Tumor Cell Biology, M/S 331, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tenn. 38105

News online

For current news from the UT Health Science Center San Antonio, please visit our news release website, like us on Facebook or follow us on Twitter.

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit http://www.ctrc.net.

Will Sansom | EurekAlert!
Further information:
http://www.uthscsa.edu

More articles from Life Sciences:

nachricht Building a brain, cell by cell: Researchers make a mini neuron network (of two)
23.05.2018 | Institute of Industrial Science, The University of Tokyo

nachricht Research reveals how order first appears in liquid crystals
23.05.2018 | Brown University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Research reveals how order first appears in liquid crystals

23.05.2018 | Life Sciences

Space-like gravity weakens biochemical signals in muscle formation

23.05.2018 | Life Sciences

NIST puts the optical microscope under the microscope to achieve atomic accuracy

23.05.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>